Rie Inoue
Papers
3
Total Citations
34
H-Index
3
About
Dr. Rie Inoue is a leading urological surgeon and researcher whose work centers on refining prognostic markers in prostate cancer, particularly following robot-assisted radical prostatectomy (RARP). Her major contributions focus on the nuanced pathological features that predict biochemical recurrence (BCR), aiming to improve risk stratification for patients. In her most-cited work (2015, 14 citations), she demonstrated that a positive surgical margin without extraprostatic extension still carries significant clinical impact. More recently (2024, 11 citations), she pioneered the analysis of cribriform morphology area ratios in Gleason score 4+4 patients, showing that the extent—not just presence—of this pattern is critical for BCR risk. Her 2019 study (9 citations) further clarified the roles of micro-lymphatic invasion and Gleason score in organ-confined disease with negative margins. Collectively, Dr. Inoue’s research bridges surgical pathology and clinical outcomes, providing actionable insights for postoperative management. Her work is instrumental in moving prostate cancer prognosis beyond traditional staging toward more granular, histology-driven predictions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3